Giles Mark T 4/A
4/A · Diffusion Pharmaceuticals Inc. · Filed Aug 6, 2019
Insider Transaction Report
Form 4/AAmended
Giles Mark T
Director
Transactions
- Award
Stock Option (Right to Buy)
2019-06-13+19,200→ 19,200 totalExercise: $3.15Exp: 2029-06-13→ Common Stock (19,200 underlying)
Holdings
- 294(indirect: By IRA)
Common Stock
- 53,513(indirect: By LLC)
Common Stock
Footnotes (1)
- [F1]The shares underlying the options vest in equal parts on the last calendar day of each month until fully vested on May 31, 2020.